LEPR and ovarian cancer: Taken together, our results demonstrate that leptin mediates the aggressiveness of epithelial cancer and offer an explanation as to why ovarian cancer patients with higher circulating serum leptin levels or leptin receptor-expressing tumors experience a worse survival rate.